Featured Research

from universities, journals, and other organizations

Software To Make Testing Of New Generic Drugs More Thorough

June 15, 2001
Ohio State University
Drug companies may evaluate new generic drugs more thoroughly than ever before, with software developed at Ohio State University.

COLUMBUS, Ohio -- Drug companies may evaluate new generic drugs more thoroughly than ever before, with software developed at Ohio State University.

Related Articles

Drug companies must prove that the generic form of a drug functions like the original before they can receive approval from the Food and Drug Administration (FDA), explained Jean Powers, professor emeritus of statistics and veterinary clinical sciences at Ohio State.

Powers and her colleagues formulated a new, improved statistical method for comparing drugs, and Edward Herderick, manager of the Biomedical Engineering Computer Center at Ohio State, wrote the software.

The Ohio State software compares sets of curves that chart drug characteristics, and takes into account all the data relating to a particular drug function.

"The FDA already has an excellent procedure for assuring that the generic drug matches the original, but we believe our procedure represents a potential improvement," she said. She added that the same procedures she, Herderick, and their colleagues developed could be adapted to compare any two sets of curves.

Powers and Herderick collaborated with Robert Bartoszynski, a former professor of statistics at Ohio State who died in 1998, and Joseph A. Pultz, Bartoszynski's former graduate student, who is now a statistician at DuPont Pharmaceuticals. A description of the software and the statistical methodology appeared in a recent issue of the journal Pharmacological Research.

In the article, the researchers show how the software compares dissolution curves -- graphs that map how quickly a drug is released into the body. This is one of several criteria that drug companies must address when seeking approval for a generic drug. Dissolution is an important factor for the consumer of a drug, since the drug must be released into the body before it can begin to take effect, Powers said.

"You wouldn't want to buy two different brands of aspirin and find out that one can begin to relieve your headache in half an hour and the other can't begin to relieve it for two hours," said Powers.

The procedure to compare the dissolution of two drugs is computationally intensive, Powers and Herderick explained. The current approach is for the drug company statisticians to chart the dissolution of each drug graphically, take averages of multiple graphs, and compare points along the averaged graphs to see if they match up.

With the Ohio State software, statisticians could compare all points of the graphs at once -- a much more comprehensive analysis.

For instance, in a typical dissolution analysis, a statistician would examine six graphs from the original drug, and six from the generic drug, for 12 graphs total. Then he or she would combine the 12 graphs into two average graphs, and compare selected points along both.

The Ohio State software can do it in only one-tenth of a second of computer time, and still examine all the points along the curves, instead of just comparing selected points on the two average curves.

If a statistician wanted to examine a larger data set -- say, 24 curves instead of 12 -- the new software could do that computation in only 10 minutes, Herderick said. He thinks that even larger computations will probably become practical in the future, as faster computers are developed.

Drug makers who are interested in testing the software can contact Herderick. The results in the Pharmacological Research paper are based on simulated dissolution curves, so he and Powers are eager to test the software in a real-world manufacturing situation. Several companies have already expressed interest.

The FDA partially funded this work. The Ohio State researchers are currently seeking more funding to extend the software to include the analysis of other drug functions besides dissolution, as well as additional statistical designs that drug companies commonly use. For instance, Powers said, the software could compare time-concentration graphs, which represent the length of time a quantity of a drug stays in the body.

The software holds applications outside of drug development, she added.

"Suppose you were designing a new fertilizer," she said. "If you changed the formula, you could use our software to see if a particular function changed."

Herderick wrote the software in the FORTRAN computer language for a Windows PC, but said it would work just as well on other operating platforms. He also said a drug company statistician wouldn't need any special training to use the software.

Story Source:

The above story is based on materials provided by Ohio State University. Note: Materials may be edited for content and length.

Cite This Page:

Ohio State University. "Software To Make Testing Of New Generic Drugs More Thorough." ScienceDaily. ScienceDaily, 15 June 2001. <www.sciencedaily.com/releases/2001/06/010615071427.htm>.
Ohio State University. (2001, June 15). Software To Make Testing Of New Generic Drugs More Thorough. ScienceDaily. Retrieved April 17, 2015 from www.sciencedaily.com/releases/2001/06/010615071427.htm
Ohio State University. "Software To Make Testing Of New Generic Drugs More Thorough." ScienceDaily. www.sciencedaily.com/releases/2001/06/010615071427.htm (accessed April 17, 2015).

Share This

More From ScienceDaily

More Computers & Math News

Friday, April 17, 2015

Featured Research

from universities, journals, and other organizations

Featured Videos

from AP, Reuters, AFP, and other news services

WikiLeaks Refuses To Let Sony Hack Die, Posts Database

WikiLeaks Refuses To Let Sony Hack Die, Posts Database

Newsy (Apr. 17, 2015) WikiLeaks&apos; Julian Assange says the hacked emails and documents "belong in the public domain." Video provided by Newsy
Powered by NewsLook.com
Scientists Create Self-Powering Camera

Scientists Create Self-Powering Camera

Reuters - Innovations Video Online (Apr. 17, 2015) American scientists build a self-powering camera that captures images without using an external power source, allowing it to operate indefinitely in a well-lit environment. Elly Park reports. Video provided by Reuters
Powered by NewsLook.com
The State Of Virtual Reality

The State Of Virtual Reality

Newsy (Apr. 17, 2015) Virtual Reality is still a young industry. What’s on offer and what should we expect from our immersive new future? Video provided by Newsy
Powered by NewsLook.com
Cybercrime Could Cost $400 Bln

Cybercrime Could Cost $400 Bln

Reuters - Business Video Online (Apr. 16, 2015) Representatives from around 160 countries gather at the Hague to discuss cyber space and cyber security, including the dilemmas and challenges regarding the evolution of the internet. Ciara Lee reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.


Breaking News:

Strange & Offbeat Stories

Space & Time

Matter & Energy

Computers & Math

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News


Free Subscriptions

Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile

Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?

Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins